Display options
Share it on
Full text links
Wiley Free PMC Article

Br J Pharmacol. 1991 Sep;104(1):258-62. doi: 10.1111/j.1476-5381.1991.tb12416.x.

The effects of idazoxan and other alpha 2-adrenoceptor antagonists on food and water intake in the rat.

British journal of pharmacology

H C Jackson, I J Griffin, D J Nutt

Affiliations

  1. Department of Pharmacology, School of Medical Sciences, University Walk, Bristol.

PMID: 1686207 PMCID: PMC1908278 DOI: 10.1111/j.1476-5381.1991.tb12416.x
Free PMC Article

Abstract

1. Idazoxan (1, 3, 10 mg kg-1, i.p.) produced a significant increase in food and water intake in freely feeding rats during the daylight phase. 2. The more selective and specific alpha 2-adrenoceptor antagonists, RX811059 (0.3, 1, 3 mg kg-1, i.p.) and RX821002 (0.3, 1, 3 mg kg-1, i.p.), did not produce hyperphagia in rats, however, the highest dose produced a significant increase in water intake. 3. The peripherally acting alpha 2-adrenoceptor antagonist, L-659,066 (1, 3, 10 mg kg-1, i.p.), did not affect food intake in the 4 h following injection, but the highest dose (10 mg kg-1), produced a large increase in water intake. 4. These results indicate that alpha 2-adrenoceptor antagonists may increase water intake by a peripherally mediated mechanism. 5. The lack of effect RX811059 and RX821002 on food intake contrasts with the large dose-related increases induced by idazoxan and suggests that the hyperphagic effects of idazoxan are not due to alpha 2-adrenoceptor blockade but may instead reflect its affinity for a non-adrenoceptor site, a property not shared by the other alpha 2-antagonists.

References

  1. Eur J Pharmacol. 1989 Aug 11;167(1):95-104 - PubMed
  2. J Pharmacol Exp Ther. 1967 Oct;158(1):150-63 - PubMed
  3. Xenobiotica. 1988 May;18(5):519-32 - PubMed
  4. Br J Pharmacol. 1986 Oct;89(2):277-86 - PubMed
  5. Psychopharmacology (Berl). 1986;89(4):414-20 - PubMed
  6. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):355-8 - PubMed
  7. Eur J Pharmacol. 1985 Sep 10;115(1):11-9 - PubMed
  8. Psychopharmacology (Berl). 1985;86(1-2):197-204 - PubMed
  9. Trends Pharmacol Sci. 1989 Sep;10(9):342-4 - PubMed
  10. J Pharmacol Exp Ther. 1988 Apr;245(1):32-40 - PubMed
  11. Eur J Pharmacol. 1984 Oct 15;105(3-4):265-72 - PubMed
  12. Brain Res. 1984 Aug 20;309(1):85-104 - PubMed
  13. Eur J Pharmacol. 1984 Nov 13;106(2):271-82 - PubMed
  14. Mol Pharmacol. 1990 Jun;37(6):876-85 - PubMed
  15. Br J Pharmacol. 1990 Apr;99(4):803-9 - PubMed
  16. Am J Physiol. 1990 Jul;259(1 Pt 2):F1-8 - PubMed
  17. Biochem Pharmacol. 1984 Aug 15;33(16):2553-7 - PubMed
  18. J Med Chem. 1984 May;27(5):570-6 - PubMed
  19. Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):75-8 - PubMed
  20. Pharmacol Ther. 1984;24(2):179-206 - PubMed
  21. Brain Res Bull. 1983 Jan;10(1):121-6 - PubMed
  22. Br J Pharmacol. 1983 Jan;78(1):159-64 - PubMed
  23. Brain Res Bull. 1981 Dec;7(6):661-4 - PubMed
  24. Br J Pharmacol. 1979 Sep;67(1):133-41 - PubMed
  25. Fed Proc. 1978 Nov;37(13):2689-93 - PubMed
  26. Physiol Behav. 1978 Jul;21(1):73-7 - PubMed
  27. Eur J Pharmacol. 1974 May;26(2):129-35 - PubMed
  28. Circ Res. 1976 May;38(5):338-46 - PubMed
  29. J Pharmacol Exp Ther. 1987 May;241(2):642-9 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources